Drug Discovery World

MAY 1, 2024

DDW’s Megan Thomas speaks to industry experts and thought leaders about the potential for therapeutic antibodies in 2024. Artificial intelligence (AI) AI is on everyone’s minds as we head into 2024; of course, this is across not just the drug discovery spectrum but is particularly relevant to therapeutic antibodies.

FDA Approval 147

FDA Approval Therapies FDA Molecular Biology 147

Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. DDW Volume 25 – Issue 1, Winter 2023/2024 The post Guide to using AAV vectors in gene therapy appeared first on Drug Discovery World (DDW). How is the titer determined?

Therapies 147

Therapies Bioinformatics Packaging Molecular Biology 147

Broad Institute

APRIL 25, 2024

By Allessandra DiCorato April 25, 2024 As night fell on July 20th, 2014, genomicist Christian Happi was at home with his family in Lagos, Nigeria when he received a phone call he would never forget. The Sentinel team has also trained more than 1,600 scientists from all 54 African countries in genomics, diagnostics, and bioinformatics.

Virus 132

Virus Hospitals Disease Government 132

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. The session ends with two presentations and two luncheon presentations.

Engineering 130

Engineering Therapies Protein Production Science 130